BioSpace News Archive

Designation recognizes products that bring improvements to the healthcare industry [25-October-2017] MOUNTAIN VIEW, Calif., Oct. 25, 2017 /PRNewswire/ -- Omnicell, Inc. announced its IV compounding solutions and XT Series Automated Dispensing Cabinets have received 2017 Innovative Technology designations from Vizient, Inc., the largest member-driven healthc

Varian today announced its fourth-quarter and full-year fiscal 2017 results.

Varian today announced it has been selected by Penn Medicine to install a Varian ProBeam Compact single-room proton therapy system in a new cancer treatment center.

This quarterly earnings call will be available via phone and webcast.

The Company recorded a net loss of $9,913,401 in the year ended June 30, 2017 and $1,758,719 in the year ended June 30, 2016.

Dentsply Sirona’s management team will host an investor conference call and live webcast at 8:30 am ET that morning.

CARMAT announces that the first international implantation of its bioprosthetic artificial heart has been performed at the National Research Center for Cardiac Surgery (Astana, Kazakhstan) in accordance with the protocol of the PIVOTAL study.

Dr. Fuchs is an internationally recognized expert in gastrointestinal cancers, cancer epidemiology and cancer drug development.

The company has selected TAMM Net as FDA consultant to lead regulatory actions for USF treatment.